Medical Devices Late Stage Investors & VC Firms

247 firms in this list, with a median first check of $1.1M. 58 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SE Sectoral Asset Management FBGDMSMM8 people	88🔒	Montreal	CA	Series B–Late Stage	—	+ Add to CRM
AG Agate Medical Investments LP	88🔒	Tel-Aviv	IL	Growth–Late Stage	—	+ Add to CRM
PA Pandect Bioventures DSKKRLRW10 people	88🔒	Woodside	US	Seed–Late Stage	—	+ Add to CRM
CL Clal Biotechnology Industries AALNNMAF8 people	88🔒	Tel Aviv	IL	Seed–Late Stage	—	+ Add to CRM
HE Healthcare Venture Partners, Llc JCMYELJD10 people	88🔒	Charleston	US	Series B–Late Stage	—	+ Add to CRM
KI KIC Ventures VLAWECJS10 people	88🔒	Fort Lauderdale	US	Growth–Late Stage	—	+ Add to CRM
CL Claremont Creek Ventures NGRHBWGO5 people	88🔒	Oakland	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
OO Oost NL JBSH2 people	88🔒	Apeldoorn	NL	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
MO Mohr Davidow Ventures BSESKFBE7 people	88🔒	San Mateo	US	Seed–Late Stage	$200K – $4M	+ Add to CRM
UN Unfold Ventures JSAJACMS7 people	88🔒	Wrocław	PL	Pre-Seed–Late Stage	$110K – $1.1M	+ Add to CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
GL Global BioAccess Fund BRLWTMSG7 people	88🔒	New York	US	Series A–Late Stage	$10M	+ Add to CRM
BI Birch Venture Capital, Inc. MWLLTH3 people	88🔒	Taipei City	TW	Seed–Late Stage	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Series A–Late Stage	$5M – $15M	+ Add to CRM
WH Whiz Partners Inc. YH安俊藤朋HF6 people	88🔒	Tokyo	JP	Seed–Late Stage	$500K – $5M	+ Add to CRM
OD ODYSSEE VENTURE JAMBSS3 people	88🔒	Paris	FR	Series A–Late Stage	$1.1M – $11M	+ Add to CRM
MA Mayo Clinic Ventures AJPA2 people	88🔒	Rochester	US	Seed–Late Stage	—	+ Add to CRM
DF DFJ DragonFund	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
VI Vision Creator	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
BS BSK Investment 백노조JK14 people	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
AX Axil Capital FSHGASJP7 people	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
AC ACORN BIOVENTURES GSAHML3 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
CE Centurium Capital FHHLJL3 people	88🔒	Xiamen	CN	Growth–Late Stage	—	+ Add to CRM

Sectoral Asset Management

MontrealSeries B–Late Stage

FBGDMSMM8 people

Agate Medical Investments LP

Tel-AvivGrowth–Late Stage

Pandect Bioventures

WoodsideSeed–Late Stage

DSKKRLRW10 people

Clal Biotechnology Industries

Tel AvivSeed–Late Stage

AALNNMAF8 people

Healthcare Venture Partners, Llc

CharlestonSeries B–Late Stage

JCMYELJD10 people

KIC Ventures

Fort LauderdaleGrowth–Late Stage

VLAWECJS10 people

Claremont Creek Ventures

OaklandSeed–Late Stage$500K – $3M

NGRHBWGO5 people

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

Oost NL

ApeldoornSeed–Late Stage$108K – $5.4M

JBSH2 people

Mohr Davidow Ventures

San MateoSeed–Late Stage$200K – $4M

BSESKFBE7 people

Unfold Ventures

WrocławPre-Seed–Late Stage$110K – $1.1M

JSAJACMS7 people

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Global BioAccess Fund

New YorkSeries A–Late Stage$10M

BRLWTMSG7 people

Birch Venture Capital, Inc.

Taipei CitySeed–Late Stage

MWLLTH3 people

Kern Capital, LLC

LarkspurSeries A–Late Stage$5M – $15M

JK1 person

Whiz Partners Inc.

TokyoSeed–Late Stage$500K – $5M

YH安俊藤朋HF6 people

ODYSSEE VENTURE

ParisSeries A–Late Stage$1.1M – $11M

JAMBSS3 people

Mayo Clinic Ventures

RochesterSeed–Late Stage

AJPA2 people

DFJ DragonFund

ShanghaiSeed–Late Stage

Vision Creator

SeoulSeed–Late Stage

BSK Investment

SeoulSeed–Late Stage

백노조JK14 people

Axil Capital

TokyoSeed–Late Stage

FSHGASJP7 people

ACORN BIOVENTURES

New YorkSeed–Late Stage

GSAHML3 people

Centurium Capital

XiamenGrowth–Late Stage

FHHLJL3 people

Data sourced from public filings and firms' own websites — see our methodology.